Optimizerx vs Sophia Genetics SA
Optimizerx is the larger business, with $109m of revenue in fiscal 2025 against $77.3m for Sophia Genetics SA (1.4 times as much). Optimizerx grew faster (18.8% against 18.6%). Optimizerx kept more of each dollar of sales as profit: a net margin of 4.7% against -102.2%. Optimizerx carries less debt relative to equity (20.5% against 101.2%).
| Latest fiscal year | OptimizerxOPRX, 2025 | Sophia Genetics SASOPH, 2025 |
|---|---|---|
| Revenue | $109m | $77.3m |
| Revenue growth | 18.8% | 18.6% |
| Net income | $5.1m | −$79.0m |
| Operating margin | 10.7% | -91.8% |
| Net margin | 4.7% | -102.2% |
| Return on equity | 4.2% | -110.0% |
| Free cash flow | $18.7m | −$36.5m |
| Cash | $23.4m | $70.3m |
| Total debt | $26.3m | $47.7m |
| Debt to equity | 20.5% | 101.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 104 | — |
| Market value | $176m | $460m |
| Price vs our value range | Above our value range | — |
| Moat score | 29 (Weak) | — |
| Insider trades, 12 months | 0 buys, 1 sales | 1 buys, 150 sales |